Millipore Sigma Vibrant Logo
Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

539648 Staurosporine, N-Benzoyl

A cell-permeable Staurosporine derivative that displays antitumor properties.

Staurosporine, N-Benzoyl MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.

Synonyms: PKG Inhibitor IX, N-Benzoylstaurosporine, CGP 41 251, PKC412, PDGFR Tyrosine Kinase Inhibitor X

Primary Target: PKC (α, β and γ), PDGFRβ, VEGFR2, Syk, PKCη, PKCδ, Flk-1, Flt3, Cdk1/B, PKA, c-Kit, c-Fgr, c-Src, VEGFR1, and EGFR
View Products on Sigmaaldrich.com
539648
Purchase on Sigma-Aldrich

Overview

Replacement Information

Key Spec Table

CAS #Empirical Formula
120685-11-2C₃₅H₃₀N₄O₄

Products

Catalogue NumberPackaging Qty/Pack
539648-1MG Plastic ampoule 1 mg
Description
OverviewA cell-permeable Staurosporine (Cat. No. 569397) derivative that displays antitumor properties. Acts as a broad-spectrum, reversible, and ATP-competitive inhibitor of PKC (α, β and γ), PDGFRβ, VEGFR2, Syk, PKCη, PKCδ, Flk-1, Flt3, Cdk1/B, PKA, c-Kit, c-Fgr, c-Src, VEGFR1, and EGFR (IC50 = 22 nM, 50 nM, 86 nM, 95 nM, 160 nM, 330 nM, 390 nM, 528 nM, 570 nM, 570 nM, 600 nM, 790 nM, 800 nM, 912 nM, and 1.0 µM, respectively). At higher concentrations, also inhibits Ins-R and IGF-1R (IC50 = 10 µM). Shown to potently inhibit the proliferation of Ba/F3 cells expressing constitutively active Flt3 (IC50 < 10 nM).
Catalogue Number539648
Brand Family Calbiochem®
SynonymsPKG Inhibitor IX, N-Benzoylstaurosporine, CGP 41 251, PKC412, PDGFR Tyrosine Kinase Inhibitor X
References
ReferencesWeisberg, E., et al. 2002. Cancer Cell 1, 433.
Fabbro, D., et al. 2000. Anticancer Drug Des. 15, 17.
Meyer, T., et al. 1999. Int. J. Cancer 81, 669.
Meyer, T., et al. 1989. Int. J. Cancer 43, 851.
Product Information
CAS number120685-11-2
ATP CompetitiveY
FormTan solid
Hill FormulaC₃₅H₃₀N₄O₄
Chemical formulaC₃₅H₃₀N₄O₄
ReversibleY
Structure formula ImageStructure formula Image
Quality LevelMQ100
Applications
Biological Information
Primary TargetPKC (α, β and γ), PDGFRβ, VEGFR2, Syk, PKCη, PKCδ, Flk-1, Flt3, Cdk1/B, PKA, c-Kit, c-Fgr, c-Src, VEGFR1, and EGFR
Primary Target IC<sub>50</sub>22 nM, 50 nM, 86 nM, 95 nM, 160 nM, 330 nM, 390 nM, 528 nM, 570 nM, 570 nM, 600 nM, 790 nM, 800 nM, 912 nM, and 1.0 µM against primary targets in the order listed
Purity≥98% by HPLC
Physicochemical Information
Cell permeableY
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Storage and Shipping Information
Ship Code Ambient Temperature Only
Toxicity Standard Handling
Storage -20°C
Protect from Light Protect from light
Do not freeze Ok to freeze
Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
Packaging Information
Packaged under inert gas Packaged under inert gas
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Catalogue Number GTIN
539648-1MG 04055977194838

Documentation

Staurosporine, N-Benzoyl SDS

Title

Safety Data Sheet (SDS) 

Staurosporine, N-Benzoyl Certificates of Analysis

TitleLot Number
539648

References

Reference overview
Weisberg, E., et al. 2002. Cancer Cell 1, 433.
Fabbro, D., et al. 2000. Anticancer Drug Des. 15, 17.
Meyer, T., et al. 1999. Int. J. Cancer 81, 669.
Meyer, T., et al. 1989. Int. J. Cancer 43, 851.
Data Sheet

Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

Revision06-February-2014 JSW
SynonymsPKG Inhibitor IX, N-Benzoylstaurosporine, CGP 41 251, PKC412, PDGFR Tyrosine Kinase Inhibitor X
DescriptionA cell-permeable Staurosporine (Cat. No. 569397) derivative that displays antitumor properties. Acts as a broad-spectrum, reversible, and ATP-competitive inhibitor of PKC (α, β and γ), PDGFRβ, VEGFR2, Syk, PKCη, PKCδ, Flk-1, Flt3, Cdk1/B, PKA, c-Kit, c-Fgr, c-Src, VEGFR1, and EGFR (IC50 = 22 nM, 50 nM, 86 nM, 95 nM, 160 nM, 330 nM, 390 nM, 528 nM, 570 nM, 570 nM, 600 nM, 790 nM, 800 nM, 912 nM, and 1.0 µM, respectively). At higher concentrations, also inhibits Ins-R and IGF-1R (IC50 = 10 µM). Shown to potently inhibit the proliferation of Ba/F3 cells expressing constitutively active Flt3 (IC50 < 10 nM).
FormTan solid
Intert gas (Yes/No) Packaged under inert gas
CAS number120685-11-2
Chemical formulaC₃₅H₃₀N₄O₄
Structure formulaStructure formula
Purity≥98% by HPLC
SolubilityDMSO (6 mg/ml)
Storage Protect from light
-20°C
Do Not Freeze Ok to freeze
Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
Toxicity Standard Handling
ReferencesWeisberg, E., et al. 2002. Cancer Cell 1, 433.
Fabbro, D., et al. 2000. Anticancer Drug Des. 15, 17.
Meyer, T., et al. 1999. Int. J. Cancer 81, 669.
Meyer, T., et al. 1989. Int. J. Cancer 43, 851.